103
Participants
Start Date
December 1, 2016
Primary Completion Date
June 1, 2020
Study Completion Date
November 15, 2020
ABTL0812 in combination with paclitaxel and carboplatin
ABTL0812 in combination with paclitaxel and carboplatin.
Abilitypharma, Barcelona
Lead Sponsor
Hospital Vall d'Hebron
OTHER
Institut Català d'Oncologia
OTHER
Hospital Clínico Universitario de Valencia
OTHER
Hospitales Universitarios Virgen del Rocío
OTHER
Centre Leon Berard
OTHER
Institut Paoli-Calmettes
OTHER
Gustave Roussy, Cancer Campus, Grand Paris
OTHER
Ability Pharmaceuticals SL
INDUSTRY